Our site is still in beta mode, Please provide your valuable feedback.

BD Veritor™ System for Rapid Detection of SARS-CoV-2

Home/COVID-19, Diagnostics, Lab Supplies, Point of Care, Urgent Care/BD Veritor™ System for Rapid Detection of SARS-CoV-2

BD Veritor™ System for Rapid Detection of SARS-CoV-2

BD Veritor™ System for Rapid Detection of SARS-CoV-2

  • 30/Tests

Description

BD Veritor™ System for Rapid Detection of SARS-CoV-2

The BD Veritor™ System for Rapid Detection of SARS-CoV-2 is a chromatographic digital immunoassay intended for the direct and qualitative detection of SARS-CoV-2 nucleocapsid antigens in nasal swabs from individuals who are suspected of COVID-19 by their healthcare provider within the first five days of the onset of symptoms. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet the requirements to perform moderate, high, or waived complexity tests. This test is authorized for use at the Point of Care (POC), i.e., inpatient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.

 

Brand

BD

Reviews

There are no reviews yet.

Be the first to review “BD Veritor™ System for Rapid Detection of SARS-CoV-2”

Your email address will not be published. Required fields are marked *

15 + 14 =